Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
Parissone F, Di Paola R, Balter R, Garzon S, Zaffagnini S, Neri M, Vitale V, Tridello G, Cesaro S. Parissone F, et al. J Pediatr Endocrinol Metab. 2020 Oct 19;34(1):25-33. doi: 10.1515/jpem-2020-0272. Print 2021 Jan 27. J Pediatr Endocrinol Metab. 2020. PMID: 33068384
Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve.
Di Paola R, Garzon S, Giuliani S, Laganà AS, Noventa M, Parissone F, Zorzi C, Raffaelli R, Ghezzi F, Franchi M, Zaffagnini S. Di Paola R, et al. Among authors: parissone f. Arch Gynecol Obstet. 2018 Nov;298(5):1029-1035. doi: 10.1007/s00404-018-4906-2. Epub 2018 Sep 21. Arch Gynecol Obstet. 2018. PMID: 30242498
A novel de novo partial xq duplication in a girl with short stature, nonverbal learning disability and diminished ovarian reserve - effect of growth hormone treatment and fertility preservation strategies: a case report and up-to-date review.
Parissone F, Pucci M, Meneghelli E, Zuffardi O, Di Paola R, Zaffagnini S, Franchi M, Santangelo E, Cantalupo G, Cavarzere P, Antoniazzi F, Piacentini G, Gaudino R. Parissone F, et al. Int J Pediatr Endocrinol. 2020;2020:1. doi: 10.1186/s13633-019-0071-z. Epub 2020 Jan 9. Int J Pediatr Endocrinol. 2020. PMID: 31938033 Free PMC article.
Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment.
Molinari S, Parissone F, Evasi V, De Lorenzo P, Valsecchi MG, Cesaro S, Fraschini D, Sangalli R, Cacace G, Biondi A, Balduzzi A, Cattoni A. Molinari S, et al. Among authors: parissone f. Eur J Endocrinol. 2021 Oct 11;185(5):717-728. doi: 10.1530/EJE-21-0351. Eur J Endocrinol. 2021. PMID: 34519276
Do we trust scientific evidence? A multicentre retrospective analysis of first IVF/ICSI cycles before and after the OPTIMIST trial.
Papaleo E, Revelli A, Costa M, Bertoli M, Zaffagnini S, Tomei F, Manno M, Rebecchi A, Villanacci R, Vanni VS, Cantatore F, Ruffa A, Colia D, Sironi M, Tessari T, Parissone F, Romanello I, Reschini M, Dallagiovanna C, Somigliana E. Papaleo E, et al. Among authors: parissone f. Hum Reprod. 2021 Apr 20;36(5):1367-1375. doi: 10.1093/humrep/deab047. Hum Reprod. 2021. PMID: 33686407
11 results